Beyond sharing data, DQS aligns multiple data sources, including sponsors’ clinical trial management system data, public registries, and clinical trial databases, to provide a single, holistic, and ...
In today’s ACT Brief, we examine how site-level data capture is becoming central to trial execution, how Merck and Mayo ...
Jonathan Andrus, co-CEO of CRIO, explains how protocol-driven eSource templates and standardized data capture are improving ...
Jonathan Andrus, co-CEO of CRIO, discusses how increased reliance on site-based technologies and eSource is strengthening ...
Mayo Clinic, for its part, described the collaboration as its first strategic partnership of this scale with a global ...
In today’s ACT Brief, we examine how SCOPE 2026 reinforced the link between speed and strategy, how AI adoption is driving ...
In today’s ACT Brief, we examine how predictive analytics are shaping portfolio decisions, how industry collaboration is ...
Angela Zubel, chief development officer, Debiopharm, discusses why 2026 marks a shift from AI pilots to broader operational ...
Angela Zubel, chief development officer, Debiopharm, explains how AI-enabled site selection, patient allocation, and real-time data monitoring can reduce costs, shorten timelines, and limit ...
Mike Wenger, chief innovation officer at CRIO, explains how AI can responsibly support data quality and monitoring with ...
In today’s ACT Brief, we examine how AI is enabling continuous trial monitoring and faster site decisions, how provider ...
Miriam Dervan, founder & CEO of mdgroup, discusses how patient-centered strategies rooted in empathy and advocacy engagement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results